AS "Repharm"Active
Key figures
Ratios
2024Balance sheet structure
Dividends
from the reportDividends paid 29 220 000 €
Summary of financial statements2009–2024
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||||||||||||
| Total current assets | 3 696 096 | 275 150 | 10 068 423 | 11 134 336 | 32 433 740 | 47 174 022 | 51 608 753 | 58 865 351 | 71 545 373 | 103 993 | 121 447 653 | 4 523 445 | 27 437 998 | 80 908 875 | 977 147 | 540 870 |
| Total non-current assets | 5 795 000 | 1 295 000 | 1 312 247 | 1 312 247 | 3 085 706 | 21 423 951 | 30 003 715 | 42 761 885 | 59 558 391 | 28 411 987 | 63 376 403 | 31 412 567 | 31 412 445 | 31 315 123 | 34 235 291 | 28 189 736 |
| Total assets | 9 491 096 | 1 570 150 | 11 380 670 | 12 446 583 | 35 519 446 | 68 597 973 | 81 612 468 | 101 627 236 | 131 103 764 | 28 515 980 | 184 824 056 | 35 936 012 | 58 850 443 | 112 223 998 | 35 212 438 | 28 730 606 |
| Balance sheet — liabilities and equity | ||||||||||||||||
| Current liabilities | 54 957 | 0 | 800 | 0 | 18 519 477 | 31 552 359 | 35 470 233 | 43 468 449 | 40 833 112 | 1381 | 53 226 188 | 22 250 688 | 34 072 954 | 28 594 688 | 17 589 131 | 20 343 886 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 13 297 | 13 881 101 | 16 350 756 | 10 330 989 | 28 241 926 | 0 | 24 252 235 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 54 957 | 0 | 800 | 0 | 18 532 774 | 45 433 460 | 51 820 989 | 53 799 438 | 69 075 038 | 1381 | 77 478 423 | 22 250 688 | 34 072 954 | 28 594 688 | 17 589 131 | 20 343 886 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | 7 866 139 | 11 | 9 809 720 | 10 875 963 | 11 718 198 | 11 864 656 | 17 173 218 | 18 012 225 | 14 568 209 | 21 607 858 | 34 560 347 | 11 390 394 | 15 837 165 | 81 391 821 | 15 333 996 | 5 443 413 |
| Total equity | 9 436 139 | 1 570 150 | 11 379 870 | 12 446 583 | 16 986 672 | 23 164 513 | 29 791 479 | 47 827 798 | 62 028 726 | 28 514 599 | 107 345 633 | 13 685 324 | 24 777 489 | 83 629 310 | 17 623 307 | 8 386 720 |
| Income statement | ||||||||||||||||
| Sales revenue | 0 | 0 | 0 | 0 | 110 209 520 | 171 605 553 | 198 053 934 | 229 039 015 | 245 655 035 | 0 | 283 007 855 | 0 | 0 | 0 | 0 | 0 |
| Operating profit | -236 | -127 | -370 | -508 | 12 880 279 | 4 691 167 | 14 837 921 | 21 590 892 | 17 278 654 | -4092 | 35 223 200 | -236 257 | -410 663 | 75 700 664 | -119 225 | -34 971 |
| Profit before income tax | 7 866 223 | 13 | 9 810 553 | 10 876 836 | 13 760 338 | 13 815 896 | 20 040 362 | 21 405 843 | 17 040 630 | 21 607 908 | 34 693 668 | 11 390 394 | 15 837 165 | 81 391 821 | 53 773 996 | 9 393 413 |
| Profit for the reporting year | 7 866 139 | 11 | 9 809 720 | 10 875 963 | 11 718 198 | 11 864 656 | 17 173 218 | 18 012 225 | 14 568 209 | 21 607 858 | 34 560 347 | 11 390 394 | 15 837 165 | 81 391 821 | 15 333 996 | 5 443 413 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | ||||||||||||||||
| Employees | 0 | 0 | 0 | 0 | 0 | — | — | — | — | 0 | — | 3 | 3 | 2 | 1 | 1 |
| Calculated dividend | 0 | 7 866 000 | 0 | 9 809 250 | 10 982 091 | 12 852 000 | 10 481 000 | 63 000 | 112 281 | 21 489 000 | 99 000 | 18 410 000 | 26 945 000 | 22 540 000 | 51 530 000 | 29 220 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: AS "Repharm"
Overview
AS "Repharm" (reg. no. 40103195532) is a joint-stock company. The company was registered in 2008 and has been in the register for 18 years. Registered address: Rīga, Mūkusalas iela 41B.
Financial results
There was no revenue in 2024. Net profit for 2024 was 5 443 413 €. The company was profitable in all 16 published years. In 2024 the company had 1 employees. At the end of 2024, total assets were 28 730 606 € and equity 8 386 720 € (29,2% of assets).
Management and owners
The company has one board member. The company holds a stake in one other active Latvian company.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.